Triple Negative Breast Cancer, "I Won't Back Down!": "LaTonia Taliaferro-Smith, PhD - "She Not Only Wanted To Have The Answers For My Sister, But Black Women in General"

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Sunday, November 4, 2012

"LaTonia Taliaferro-Smith, PhD - "She Not Only Wanted To Have The Answers For My Sister, But Black Women in General"

"LaTonia Taliaferro-Smith, PhD, a researcher at Winship Cancer Institute at Emory University is working hard in finding a cure for cancer. Eight women in her husband's family have been diagnosed with breast cancer. She specializes on triple negative breast cancer, a particularly aggressive form of breast cancer that disproportionately affects black women and Latino women."

Read more here: http://www.newsobserver.com/2012/10/30/2448753/researcher-takes-her-breast-cancer.html#storylink=rss?utm_source=twitterfeed&utm_medium=twitter#storylink=cpy

Researcher takes her breast cancer work personally - Health/Science - NewsObserver.com
(Click link for full story)

The Discriminatory Cancer
http://whsc.emory.edu/home/publications/health-sciences/emory-health/fall11/the-discriminatory-cancer.html#.UJcRHhyv_Eo (Click link for full story)